Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg‐interferon α‐2b and ribavirin
MANGIA, A., DALGARD, O., MINERVA, N., VERBAAN, H., BACCA, D., RING‐LARSEN, H., COPETTI, M., CARRETTA, V., PIAZZOLLA, V., COZZOLONGO, R., MOTTOLA, L., ANDRIULLI, A.
Published in Alimentary pharmacology & therapeutics (01.06.2010)
Published in Alimentary pharmacology & therapeutics (01.06.2010)
Get full text
Journal Article
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin
Mangia, A, Dalgard, O, Minerva, N, Verbaan, H, Bacca, D, Ring-Larsen, H, Copetti, M, Carretta, V, Piazzolla, V, Cozzolongo, R, Mottola, L, Andriulli, A
Published in Alimentary pharmacology & therapeutics (01.06.2010)
Published in Alimentary pharmacology & therapeutics (01.06.2010)
Get full text
Journal Article
1135 IL28B CC GENOTYPE IS ASSOCIATED WITH HIGHER ON-TREATMENT-RESPONSE RATES IN PTS WITH HCV-3: INTERIM RESULTS OF THE WRITE STUDY
Piazzolla, V, Forte, P, Francavilla, R, Barbarini, G, Mecenate, F, Carrado, M, Minerva, N, Bacca, D, Carretta, V, Pellicelli, A, Romano, M, Montalto, G, Zignego, L, Nosotti, L, De Luna, A, Agostinacchio, E, Cuccorese, G, Luchi, S, Bertino, G, Santoro, R, Mottola, L, Petruzzellis, D, Facciorusso, D, Mangia, A
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
1331 LACK OF ASSOCIATION BETWEEN IL28B VARIANTS AND HBSAG CLEARANCE AFTER INTERFERON TREATMENT
Mangia, A, Santoro, R, Mottola, L, Fasano, M, Minerva, N, Bacca, D, Piazzolla, V, Carretta, V, Termite, A, Agostinacchio, E, Facciorusso, D, Petruzzellis, D, Santantonio, T
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin
Andriulli, A., Cursaro, C., Cozzolongo, R., Iacobellis, A., Valvano, M. R., Mangia, A., Minerva, N., Bacca, D., Stanzione, M., Scuteri, A., Montalto, G., Andreone, P.
Published in Journal of viral hepatitis (01.01.2009)
Published in Journal of viral hepatitis (01.01.2009)
Get full text
Journal Article
630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B
Mangia, A, Dalgard, O, Minerva, N, Verbaan, H, Scotto, G, Bacca, D, Agostinacchio, E, Bjoro, K, Carretta, V, Piazzolla, V, Cozzolongo, R, Romano, M, Mottola, L, Andriulli, A
Published in Journal of hepatology (2009)
Published in Journal of hepatology (2009)
Get full text
Journal Article
[7] IN PTS WHO CLEAR HCVRNA AT WEEK 12, SVR IS HIGHER AFTER 72 THAN AFTER 48 WEEKS TX: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (RCT)
Mangia, A, Minerva, N, Bacca, D, Carretta, V, Vuturo, N, Ricci, G.L, Romano, M, Cela, M, Scotto, G, Cristoforo, G, Cozzolongo, R, Mottola, L, Andriulli, A
Published in Journal of hepatology (01.04.2007)
Published in Journal of hepatology (01.04.2007)
Get full text
Journal Article
8 FACTORS PREDICTIVE OF RELAPSE IN GENOTYPE 2 AND 3 PTS TREATED FOR 12 WEEKS WITH PEGIFN ALFA 2B AND WEIGHT BASED RIBAVIRIN COMBINATION
Mangia, A, Minerva, N, Bacca, D, Cozzolongo, R, Agostinacchio, E, Sogari, F, Vinelli, F, Scotto, G, Ricci, G.L, Romano, M, Carretta, V, Petruzzellis, D, Piazzolla, V, Spirito, F, Andriulli, A
Published in Journal of hepatology (2008)
Published in Journal of hepatology (2008)
Get full text
Journal Article
Early discontinuation of ribavirin in HCV genotype 2 and 3 patients undergoing short-treatment duration with Peg-interferon alfa 2a and ribavirin
Andriulli, A, Andreone, P, Cursaro, C, Cozzolongo, R, Minerva, N, Iacobellis, A, Mangia, A, Bacca, D, Stanzione, M, Scuteri, A, Montalto, G
Published in Digestive and liver disease (2007)
Published in Digestive and liver disease (2007)
Get full text
Journal Article
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, Alessandra, Santoro, Rosanna, Minerva, Nicola, Ricci, Giovanni L, Carretta, Vito, Persico, Marcello, Vinelli, Francesco, Scotto, Gaetano, Bacca, Donato, Annese, Mauro, Romano, Mario, Zechini, Franco, Sogari, Fernando, Spirito, Fulvio, Andriulli, Angelo
Published in The New England journal of medicine (23.06.2005)
Published in The New England journal of medicine (23.06.2005)
Get full text
Journal Article
THU-324 - The evolution of treatment for HCV Genotype 3 (GT3) infected patients with advanced fibrosis/cirrhosis over time
Mangia, A., Cenderrello, G., Copetti, M., Santoro, R., Sogari, F., Piazzolla, V., Minerva, N., Mazzola, M., Losappio, R., Vincenzo, P., Spinzi, G., Potenza, D., Stefano, G.D.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
The evolution of treatment for HCV Genotype 3 (GT3) infected patients with advanced fibrosis/cirrhosis over time
Mangia, A., Cenderrello, G., Copetti, M., Santoro, R., Sogari, F., Piazzolla, V., Minerva, N., Mazzola, M., Losappio, R., Vincenzo, P., Spinzi, G., Potenza, D., Stefano, G.D.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
High SVR rates in patients with and without cirrhosis treated in real life with Sofosbuvir/Velpatasvir (SOF/VEL) combination for 12 weeks without Ribavirin (RBV)
Mangia, A., Piazzolla, V., Losappio, R., Mazzola, M., Visaggi, E., Bacca, D., Sogari, F., Potenza, D., Santoro, R., Carraturo, I., Tagarielli, V., Lauletta, G., Giannelli, A., Gesualdo, A., Minerva, N.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
THU-323 - High SVR rates in patients with and without cirrhosis treated in real life with Sofosbuvir/Velpatasvir (SOF/VEL) combination for 12 weeks without Ribavirin (RBV)
Mangia, A., Piazzolla, V., Losappio, R., Mazzola, M., Visaggi, E., Bacca, D., Sogari, F., Potenza, D., Santoro, R., Carraturo, I., Tagarielli, V., Lauletta, G., Giannelli, A., Gesualdo, A., Minerva, N.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
A study of factors influencing intestinal parasites in dogs
Martini, M, Poglayen, G, Minerva, N, Zanangeli, A
Published in Annali dell'Istituto superiore di sanità (1992)
Get full text
Published in Annali dell'Istituto superiore di sanità (1992)
Journal Article
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon a-2b and ribavirin
Mangia, A, DALGARD, O, Minerva, N, Verbaan, H, Bacca, D, Ring-Larsen, H, COPETTI, M, Carretta, V, PIAZZOLLA, V, COZZOLONGO, R, Mottola, L, Andriulli, A
Published in Alimentary pharmacology & therapeutics (01.06.2010)
Published in Alimentary pharmacology & therapeutics (01.06.2010)
Get full text
Journal Article
A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C
Mangia, A., Ricci, G. L., Persico, M., Minerva, N., Carretta, V., Bacca, D., Cela, M., Piattelli, M., Annese, M., Maio, G., Conte, D., Guadagnino, V., Pazienza, V., Festi, D., Spirito, F., Andriulli, A.
Published in Journal of viral hepatitis (01.05.2005)
Published in Journal of viral hepatitis (01.05.2005)
Get full text
Journal Article
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C
Mangia, A, Ricci, G L, Persico, M, Minerva, N, Carretta, V, Bacca, D, Cela, M, Piattelli, M, Annese, M, Maio, G, Conte, D, Guadagnino, V, Pazienza, V, Festi, D, Spirito, F, Andriulli, A
Published in Journal of viral hepatitis (01.05.2005)
Published in Journal of viral hepatitis (01.05.2005)
Get full text
Journal Article